These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 25514064)
21. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870 [TBL] [Abstract][Full Text] [Related]
22. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study. McIntyre A; Gendron A; McIntyre A Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199 [TBL] [Abstract][Full Text] [Related]
23. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725 [TBL] [Abstract][Full Text] [Related]
24. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation. Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641 [TBL] [Abstract][Full Text] [Related]
25. Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment. Ball SG; Atkinson S; Sparks J; Bangs M; Goldberger C; Dubé S J Clin Psychopharmacol; 2015 Jun; 35(3):266-72. PubMed ID: 25815754 [TBL] [Abstract][Full Text] [Related]
26. Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control. Kasper S; Corruble E; Hale A; Lemoine P; Montgomery SA; Quera-Salva MA Int Clin Psychopharmacol; 2013 Jan; 28(1):12-9. PubMed ID: 23023074 [TBL] [Abstract][Full Text] [Related]
27. Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment. Ball SG; Ferguson MB; Martinez JM; Pangallo BA; Nery ES; Dellva MA; Sparks J; Zhang Q; Liu P; Bangs M; Goldberger C J Clin Psychiatry; 2016 May; 77(5):635-42. PubMed ID: 27035159 [TBL] [Abstract][Full Text] [Related]
28. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents. Strawn JR; Mills JA; Poweleit EA; Ramsey LB; Croarkin PE Pharmacotherapy; 2023 Jul; 43(7):675-690. PubMed ID: 36651686 [TBL] [Abstract][Full Text] [Related]
29. Spotlight on sertraline in the management of major depressive disorder in elderly patients. Muijsers RB; Plosker GL; Noble S CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038 [TBL] [Abstract][Full Text] [Related]